SML1829
ADX71743
≥98% (HPLC)
别名:
6-(2,4-Dimethylphenyl)-2-ethyl-6,7-dihydrobenzo[d]oxazol-4(5H)-one
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C17H19NO2
化学文摘社编号:
分子量:
269.34
UNSPSC Code:
12352200
NACRES:
NA.77
MDL number:
产品名称
ADX71743, ≥98% (HPLC)
InChI key
CPKZCQHJDFSOJT-UHFFFAOYSA-N
SMILES string
CC1=CC(C)=CC=C1C2CC(OC(CC)=N3)=C3C(C2)=O
assay
≥98% (HPLC)
form
powder
color
white to beige
solubility
DMSO: 5 mg/mL, clear (warmed)
storage temp.
−20°C
Quality Level
Biochem/physiol Actions
ADX71743 is a brain-penetrant, selective and potent negative allosteric modulator of metabotropic glutamate receptor 7 (mGlu7).
ADX71743 is a brain-penetrant, selective and potent negative allosteric modulator of metabotropic glutamate receptor 7 (mGlu7). In one study ADX71743 exhibited an anxiolytic-like profile in rat and mouse models without causing impairment of locomotor activity. In another study it induced absence epileptic seizures and lethargy.
ADX71743 is known to negatively regulate the effect of mGlu7 (metabotropic glutamate receptor subtype 7), which is associated with a number of anxiety disorders.
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Rachel D Moloney et al.
Neurobiology of stress, 2, 28-33 (2016-02-05)
Glutamate, the main excitatory neurotransmitter in the central nervous system, exerts its effect through ionotropic and metabotropic receptors. Of these, group III mGlu receptors (mGlu 4, 6, 7, 8) are among the least studied due to a lack of pharmacological
Valériane Tassin et al.
Frontiers in neural circuits, 10, 31-31 (2016-05-21)
Mutation of the metabotropic glutamate receptor type 7 (mGlu7) induces absence-like epileptic seizures, but its precise role in the somatosensory thalamocortical network remains unknown. By combining electrophysiological recordings, optogenetics, and pharmacology, we dissected the contribution of the mGlu7 receptor at
Mikhail Kalinichev et al.
The Journal of pharmacology and experimental therapeutics, 344(3), 624-636 (2012-12-22)
Metabotropic glutamate receptor 7 (mGlu(7)) has been suggested to be a promising novel target for treatment of a range of disorders, including anxiety, post-traumatic stress disorder, depression, drug abuse, and schizophrenia. Here we characterized a potent and selective mGlu(7) negative
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持